An efficient Pd@MIL-101(Cr) catalyst prepared with MOCVD approach for 2-butyne-1,4-diol hydrogenation with excellent activity, stability and selectivity.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: